Rick Simpson Oil (RSO) in Bingham County, Idaho: A Complete Guide by OilWell Cannabis

If you or someone you love in Bingham County is exploring alternative options for managing chronic pain, inflammation, sleep disorders, or other health challenges, you’ve likely come across Rick Simpson Oil (RSO)—one of the most well-known cannabis extracts in the world. But what exactly is RSO, and how does it differ from modern, lab-tested formulations like those offered by OilWell Cannabis?

At OilWell, we believe in honest education, scientific transparency, and patient empowerment. That’s why we’ve created this comprehensive guide—so Bingham County residents can make informed decisions about RSO, its history, its risks, and how modern formulations (like ours) have evolved to address the limitations of traditional RSO while preserving its therapeutic potential.

What Is Rick Simpson Oil (RSO)? The History & Legacy

Who Was Rick Simpson?

Rick Simpson was a Canadian power engineer born in 1949 in Nova Scotia. He wasn’t a doctor, scientist, or medical researcher—he was a working-class man who turned to cannabis after the medical system failed him.

In 1997, Simpson suffered a serious head injury while working at a hospital in Moncton, New Brunswick. The accident left him with persistent tinnitus, dizziness, and post-concussion symptoms that conventional medications couldn’t resolve. When he asked his doctor about cannabis as a potential treatment, the request was denied. Frustrated but determined, Simpson began using cannabis on his own and reported that it provided more relief than any pharmaceutical he had tried.

His interest in cannabis deepened after learning about a 1974 NIH-funded study at the Medical College of Virginia, where researchers found that THC slowed or shrunk tumors in mice. Though the study was never replicated in human trials, it became a foundational reference point for Simpson’s later advocacy.

The Turning Point: Simpson’s 2003 Skin Cancer Claim

The defining moment in Simpson’s story came in 2003 when he claimed that three bumps on his arm were diagnosed as basal cell carcinoma (a type of skin cancer). Instead of pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and reported that the bumps disappeared within four days.

Important Context:
Simpson’s account was personal testimony, not medical evidence. There was no independent medical verification, biopsy confirmation, or peer-reviewed documentation of his outcome. However, this experience became the origin story of Rick Simpson Oil (RSO) and the foundation of a global movement around concentrated cannabis extracts.

The Crusade: Spreading the Oil for Free

After his 2003 experience, Simpson dedicated himself to producing and distributing concentrated cannabis oil for free to cancer patients and others in his community. He operated out of his property in Maccan, Nova Scotia, making large batches of oil and giving it away without charge to people suffering from:

• Cancer
• Chronic pain
• Diabetes
• Infections
• Glaucoma
• Arthritis
• Depression
• Insomnia
• Multiple sclerosis

His story reached a global audience through the 2005 documentary Run From The Cure, which framed his work as a grassroots challenge to pharmaceutical and governmental interests. The film was distributed freely online and became one of the most influential cannabis advocacy documentaries of its time.

Legal Troubles & Simpson’s Departure from Canada

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police (RCMP) raided his property in 2005 and again in 2009, seizing plants and equipment. He was charged with cannabis cultivation, possession, and trafficking and eventually left Canada for Europe, continuing his advocacy from abroad.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story, detailing his personal experiences, oil-making process, and philosophical views on cannabis, medicine, and institutional suppression. He maintained that cannabis oil could cure cancer and that pharmaceutical companies, governments, and medical institutions were actively suppressing this knowledge to protect their financial interests.

Important Context:
Simpson’s conspiratorial framing was not unique—it reflected a worldview shared by many in the early cannabis movement. While his claims about institutional suppression were never substantiated, they were culturally significant in shaping the public’s perception of cannabis as a forbidden medicine.

The Traditional RSO Protocol: What Simpson Recommended

Simpson’s core treatment recommendation was a structured 90-day oral protocol designed to deliver 60 grams (about 60 mL) of concentrated cannabis oil. He described this as a cancer treatment protocol, though he also recommended it for numerous other conditions.

The 60-Gram, 90-Day Regimen

Phase	Dose	Frequency	Total Daily Intake	Notes
Week 1	~10-15 mg (half a grain of rice)	3x/day (morning, afternoon, bedtime)	30-45 mg	Start small to build THC tolerance
Weeks 2-5	Double dose every 4 days	3x/day	Gradually increase to ~1,000 mg/day	Slow ramp-up to minimize psychoactive effects
Weeks 5-12	~333 mg per dose	3x/day	~1,000 mg/day	Maintain full dose until 60 grams consumed
Post-Protocol	1-2 grams/month	Indefinitely	1-2 grams/month	Maintenance dosing for long-term health

Administration Methods

• Primary (Oral/Sublingual): Simpson recommended placing the oil under the tongue or swallowing it for systemic absorption.
• Topical: For skin cancers, he suggested applying the oil directly to lesions and covering with a bandage.
• Inhalation (Not Recommended as Primary): Simpson acknowledged that smoking or vaporizing could provide immediate symptom relief (e.g., pain, nausea) but did not consider it a primary treatment method.

Tolerance & Psychoactive Effects

• Simpson claimed that patients would develop significant THC tolerance within 3-4 weeks of consistent dosing.
• He considered the psychoactive effects (euphoria, sedation, disorientation) a minor and temporary side effect and urged patients not to let the “high” discourage them.
• He recommended taking initial doses at night to sleep through the most intense effects.
• Driving or operating machinery was strongly discouraged during the titration period.

Dietary & Lifestyle Recommendations

Simpson also advocated for dietary changes alongside the oil protocol, including:

• Reducing sugar intake
• Avoiding processed foods
• Improving overall nutrition

However, his dietary advice was general and secondary to the oil protocol.

Important Context: Evaluating the Protocol

Simpson’s protocol was not developed through clinical trials, dose-finding studies, or formal research. Several critical concerns apply:

✅ No controlled trial validation – There are no published randomized controlled trials (RCTs), cohort studies, or well-documented case series evaluating this specific protocol for any condition.

✅ Crude, unstandardized material – The 60-gram quantity assumed a single-strain, THC-dominant extract with no standardized potency. Actual THC content per gram of traditional RSO varied widely.

✅ Extremely high THC exposure – At peak dosing, patients consumed ~600-900 mg of delta-9 THC per day—far exceeding anything studied in controlled clinical settings. (For comparison, the FDA-approved synthetic THC drug dronabinol is typically dosed at 2.5-20 mg/day.)

✅ Real risks at these doses – Consuming 600-900 mg of THC daily carries serious risks, including:

• Severe intoxication
• Anxiety or panic attacks
• Tachycardia (rapid heart rate)
• Hypotension (low blood pressure)
• Impairment & dependency risks
• Cannabis use disorder

✅ Oncology context – Patients with active cancer are often medically complex. Using unregulated, unstandardized cannabis oil as a primary treatment—potentially in place of proven therapies—introduces significant harm risks.

What Was Traditional RSO? The Product Behind the Protocol

Traditional RSO was not a lab-tested, standardized medicine—it was a crude, unregulated cannabis extract defined by Simpson’s method and materials.

Source Material

• Simpson used high-THC, indica-dominant cannabis strains (he believed indica strains produced better therapeutic outcomes).
• There was no strain standardization—the starting material varied by availability and growing season.

Extraction Solvent

• Simpson originally used naphtha (a petroleum-based solvent found in lighter fluid, Varsol, etc.).
• Later, he also endorsed 99% isopropyl alcohol as an alternative.
• Neither naphtha nor isopropyl alcohol is food-grade—both carry significant residual solvent risks.

Extraction Process (8 Steps)

1. Dry cannabis plant material was placed in a bucket.
2. The material was covered with solvent and agitated to dissolve cannabinoids.
3. The solvent was poured off through a filter (cheesecloth or similar).
4. The process was repeated a second time with fresh solvent on the same plant material.
5. The combined solvent washes were heated in a rice cooker to evaporate the solvent.
6. A thick, dark oil remained at the bottom.
7. The oil was transferred into oral syringes for storage and dosing.
8. No lab testing was performed—every batch was different.

Appearance & Physical Characteristics

• Nearly black, tar-like, sticky oil with a strong cannabis odor.
• Could carry a faint solvent-residual smell depending on purging.
• Thick and difficult to handle at room temperature but became more fluid when warmed.

Cannabinoid Profile

• THC-dominant (60-90% estimated) – The heat of solvent evaporation fully decarboxylated THCa into delta-9 THC.
• Minor cannabinoids present at natural ratios – Whatever CBD, CBN, CBC, CBG, etc., the source strain contained were included, but not measured or controlled.
• No ratio control – The profile was entirely dependent on the source plant’s genetics and growing conditions.

Terpene Content: Minimal to None

• The solvent + heat process destroyed terpenes—traditional RSO had virtually no terpene content.
• This is a major difference from modern formulations (like OilWell’s), which preserve or reintroduce terpenes for potential entourage effects.

Standardization & Testing: None

• No Certificate of Analysis (COA) – Every batch was different.
• No cannabinoid quantification – THC content was estimated, not measured.
• No contaminant screening – No testing for pesticides, heavy metals, or residual solvents.

Residual Solvent Risk: A Major Safety Concern

• Naphtha is a petroleum hydrocarbon mixture that may contain benzene, toluene, and other carcinogens.
• Isopropyl alcohol is cleaner but still not intended for internal consumption.
• Incomplete solvent purging (difficult to verify without lab testing) leaves potentially harmful residues in the finished oil.

Modern extraction methods (food-grade ethanol, supercritical CO₂) address this problem by eliminating toxic solvents and allowing validated lab testing for residual solvents.

Simpson’s Claims vs. The Evidence: What Does Science Actually Say?

Simpson made expansive therapeutic claims about RSO, including that it could:
✔ Cure cancer (including terminal cases)
✔ Treat diabetes, chronic pain, infections, glaucoma, arthritis, depression, insomnia, and multiple sclerosis

But how do these claims hold up against the actual evidence?

What Simpson Was NOT

• Not a scientist, doctor, or researcher – He had no formal training in medicine, oncology, or pharmacology.
• Never conducted or published a clinical trial – His evidence was personal experience and testimonials, not controlled studies.
• No peer-reviewed publications – His claims were never subjected to scientific scrutiny.

What the Preclinical Literature Shows

There is preclinical (lab and animal) evidence suggesting that THC and CBD may have anticancer properties, including:

• Inducing apoptosis (programmed cell death) in cancer cells
• Inhibiting tumor proliferation (growth)
• Reducing angiogenesis (blood vessel formation that feeds tumors)

Key Studies:

• Velasco et al. (2012) – Reviewed preclinical evidence on cannabinoids as antitumor agents (Nature Reviews Cancer).
• Guzmán et al. (2006) – Conducted a pilot clinical study on THC in glioblastoma patients (British Journal of Cancer).

What the Preclinical Literature Does NOT Show

❌ No human clinical trial has demonstrated that RSO (or any cannabis oil) cures cancer.
❌ The gap between lab/animal results and human outcomes is vast—most cancer treatments that work in mice fail in human trials.
❌ Several small human trials (e.g., glioblastoma studies) have been conducted, but results have not supported cure claims.

Institutional Positions on Cannabis & Cancer

Organization	Position on Cannabis as a Cancer Treatment
National Cancer Institute (NCI)	Acknowledges cannabinoid research in lab/animal models but does not endorse cannabis as a cancer treatment.
U.S. Food and Drug Administration (FDA)	Has not approved any cannabis plant product for cancer treatment. Approved cannabinoid drugs (Epidiolex, dronabinol) are for other indications (seizures, nausea, appetite loss).
Health Canada	Has never approved RSO for cancer treatment.
National Center for Complementary and Integrative Health (NCCIH)	States that strongest evidence is for epilepsy, chemo nausea, and HIV/AIDS appetite, not cancer cure.

What Simpson Got Right

✅ Brought attention to cannabinoids as a serious area of biomedical research when most of the world was ignoring or suppressing it.
✅ Helped create the political and social conditions for the legal cannabis industry and cannabinoid research infrastructure that exists today.
✅ Made “RSO” the most recognized term for full-spectrum cannabis extract in the consumer vocabulary.

What He Overstated

❌ The leap from preclinical signals to “cancer cure” was not (and still is not) supported by human evidence.
❌ Encouraging patients to rely on RSO instead of proven cancer therapies (surgery, radiation, chemotherapy, immunotherapy) carries real harm risks.
❌ Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine.

The Legacy of Rick Simpson: How RSO Evolved

The term “RSO” is now used broadly—and often loosely—across the legal cannabis industry. Many products labeled as RSO today bear little resemblance to what Simpson originally made.

Simpson’s Criticism of Commercial RSO

Simpson was anti-commercial—he gave his oil away for free and believed that medicine should not be profit-driven. He criticized modern RSO products for:

• Departing from his original method
• Being sold for profit rather than distributed freely
• Not meeting his standards for potency and purity

This creates a philosophical tension:

• Was the commercialization of RSO an improvement (through quality control, lab testing, and dosing precision)?
• Or was it a betrayal (through profit extraction and regulatory gatekeeping)?

The cannabis community remains divided on this question.

Modern RSO Has Evolved Substantially

Today’s RSO products (like OilWell’s) have addressed many of the limitations of traditional RSO, including:
✅ Standardized cannabinoid profiles (no more batch-to-batch variability)
✅ Lab testing for potency and contaminants (pesticides, heavy metals, residual solvents)
✅ Multi-cannabinoid formulations (not just THC-dominant)
✅ Terpene preservation (for potential entourage effects)
✅ Patient-controlled potency (THCa allows non-psychoactive use)
✅ Multiple delivery formats (sublingual oil, vape cartridges)

Traditional RSO vs. Modern Formulated RSO: A Side-by-Side Comparison

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction Method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂
Cannabinoid Profile	THC-dominant, uncontrolled	7 defined cannabinoids at specific ratios
Terpene Content	Destroyed by high-heat process	Live terpenes at 5% with defined 7-terpene profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets
Lab Testing	Not available or performed	Full panel testing (potency, terpenes, pesticides, heavy metals, residual solvents, microbial)
Residual Solvents	Significant risk with naphtha	Controlled and tested (solvent-free)
Dosing Precision	Approximate, syringe-based	Measured per mL with known cannabinoid content (553 mg/mL)
Product Formats	Single thick oil only	Sublingual oil + vape cartridge with format-specific formulas
THCa Preservation	No—fully decarboxylated by heat	Yes—THCa included as a separate ingredient (1,500 mg)
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

OilWell’s RSO is not traditional RSO—it’s a modern, evidence-informed formulation that addresses the key limitations of Simpson’s original approach while preserving its therapeutic potential.

1. Multi-Cannabinoid Approach

• Traditional RSO: Relied on whatever single strain the maker grew or sourced.
• OilWell RSO: Intentionally includes seven cannabinoids (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC) because cannabinoid diversity may enhance therapeutic effects (entourage effect).

2. Terpene Preservation & Addition

• Traditional RSO: Had no terpenes due to solvent and heat destruction.
• OilWell RSO: Includes live terpenes at 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene) because terpenes may influence absorption, effects, and tolerability.

3. THCa as a Separate Ingredient

• Traditional RSO: Fully decarboxylated—all THCa converted to THC.
• OilWell RSO: Preserves THCa at 1,500 mg as a distinct ingredient because THCa has potential non-psychoactive benefits (anti-inflammatory, neuroprotective).

4. Reduced Delta-9 THC Dominance

• Traditional RSO: 60-90% delta-9 THC (extremely high psychoactive risk).
• OilWell RSO: Only 90 mg delta-9 THC (well under 0.3% legal limit) + 6,000 mg delta-8 THC (less psychoactive than delta-9) + 4,500 mg CBD, 3,000 mg CBG, 750 mg CBN, 750 mg CBC.

5. Product Format Innovation

• Traditional RSO: Only one format—thick oral oil.
• OilWell RSO: Two formats—sublingual oil (sustained relief) + vape cartridge (fast relief).

Solvent Safety & Extraction Evolution

One of the biggest safety concerns with traditional RSO was the use of naphtha or isopropyl alcohol—neither of which is food-grade.

• Naphtha is a petroleum-based solvent that may contain benzene, toluene, and other carcinogens.
• Isopropyl alcohol is cleaner but still not intended for internal consumption.
• Incomplete solvent purging (difficult to verify without lab testing) leaves potentially harmful residues.

Modern extraction methods (food-grade ethanol, supercritical CO₂) eliminate this risk and allow for validated lab testing to ensure no residual solvents remain.

The Decarboxylation Question: Patient-Controlled Potency

Traditional RSO Was Always Fully Decarboxylated

The heat involved in solvent evaporation (60-80°C for naphtha, 82°C for isopropyl alcohol) converted all THCa into delta-9 THC, leaving no non-psychoactive option.

OilWell RSO Preserves THCa for Patient Control

OilWell’s sublingual formula contains 1,500 mg of THCa in its acidic, non-psychoactive form. This creates three distinct usage options:

Option 1: Raw (Non-Psychoactive)

• All 1,500 mg THCa stays in its acidic form—zero psychoactive effects.
• Potential benefits: Anti-inflammatory (COX-2 inhibition), neuroprotective (PPARγ agonism).
• Best for: Daytime use, work, driving, parenting—no impairment.

Option 2: Fully Activated (Home Decarboxylation)

• Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container.
• 1,500 mg THCa converts to ~1,315 mg delta-9 THC.
• Total delta-9 THC after decarboxylation: ~1,405 mg (1,315 mg from THCa + 90 mg already in formula).
• Combined with 6,000 mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional RSO—100% legally, because decarboxylation happens after purchase, at the customer’s discretion.

Option 3: Vape (Instant Decarboxylation)

• The RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff.
• Fastest onset (1-2 minutes)—ideal for acute symptom relief (breakthrough pain, panic, nausea).

The Chemistry Behind Decarboxylation

• THCa molecular weight: 358.47 g/mol
• THC molecular weight: 314.47 g/mol
• Conversion ratio: 1 mg THCa ≈ 0.877 mg delta-9 THC (due to CO₂ loss during decarboxylation).

This design puts the potency decision entirely in the customer’s hands—aligning with Simpson’s principle that patients should control their own medicine, but implementing it through actual product chemistry rather than rhetoric.

Terpene Loss in Traditional RSO

Why Traditional RSO Had No Terpenes

• Terpenes are volatile—most begin to evaporate at 21-157°C.
• Solvent extraction dissolved terpenes into the solvent wash.
• High-heat evaporation (60-82°C) volatilized terpenes before cannabinoids degraded.

OilWell RSO Includes Live Terpenes at 5%

OilWell’s formula includes a defined seven-terpene profile (same for both sublingual oil and vape cartridge):

Terpene	Aroma/Flavor	Potential Benefits
Limonene	Citrus, bright	Mood enhancement, stress relief
Myrcene	Earthy, musky	Relaxation, sedation
β-Caryophyllene	Pepper, spice	Anti-inflammatory (CB2 agonist)
Pinene	Pine, forest	Alertness, memory support
Linalool	Floral, lavender	Calming, anxiety relief
Humulene	Earthy, woody	Anti-inflammatory, appetite suppressant
Terpinolene	Piney, fruity	Antioxidant, uplifting

Why terpenes matter:

• Enhance absorption and effects (entourage effect).
• Improve sensory experience (flavor, aroma).
• May contribute to therapeutic outcomes (though human evidence is still developing).

Evidence Standards Then vs. Now

Simpson Operated in a Pre-Legalization, Pre-Testing Era

• No regulatory framework for cannabis products.
• No standardized lab testing (no COAs, no contaminant screening).
• No legal pathway for clinical research on cannabis oil protocols.
• Personal experience was the primary evidence currency.

OilWell’s Evidence-Based Approach

This document applies a formal evidence hierarchy:

1. Human clinical evidence (strongest)
2. Systematic reviews & meta-analyses
3. Institutional summaries (NIH, FDA, NCCIH)
4. Preclinical & mechanistic literature (weakest)

Every claim is tied to specific peer-reviewed sources with evidence strength clearly labeled.

Simpson’s Protocol vs. Modern Dosing Considerations

Simpson’s 60-gram/90-day protocol was designed for a crude, single-strain, THC-dominant extract. Direct comparison to OilWell’s standardized, multi-cannabinoid formula is not straightforward—the products are fundamentally different.

Key Differences

Factor	Simpson’s Traditional RSO	OilWell RSO
Cannabinoid Concentration	Unknown, variable	553 mg/mL (16,590 mg total)
Cannabinoid Ratios	~60-90% delta-9 THC	7 cannabinoids: CBD (4,500 mg), CBG (3,000 mg), delta-8 THC (6,000 mg), THCa (1,500 mg), delta-9 THC (90 mg), CBN (750 mg), CBC (750 mg)
Terpene Presence	None	Live terpenes at 5%
Delta-9 THC Exposure	~600-900 mg/day at peak	Only 90 mg total in bottle (3 mg/mL)
Psychoactive Control	Always psychoactive (fully decarboxylated)	Patient-controlled (raw = non-psychoactive; decarbed = psychoactive)

Dosing Guidance for OilWell RSO

Important Disclaimer:
The following usage contexts are informed by cannabinoid research but are not medical prescriptions. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products.

Chemotherapy-Related Nausea & Appetite Support

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment.
• Acute breakthrough nausea: 2-3 vape puffs (1-2 minute onset).
• Post-chemo: 0.5 mL sublingual every 6 hours as needed.
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN).
• Evidence context: Delta-8 THC antiemetic [9], delta-9 THC nausea/vomiting [1][13], CBD anxiolytic buffering [3].

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime (non-psychoactive): 0.3-0.5 mL raw sublingual (anti-inflammatory without impairment).
• Nighttime (psychoactive): 0.5-1.0 mL decarboxylated sublingual (combines pain relief + CBN sleep support).
• Breakthrough pain: Vape as needed for rapid onset.
• Evidence context: CBD pain [4], delta-9 THC pain [13], β-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12].

Sleep Support

• Before bed: 1.0-2.0 mL sublingual.
• At 2.0 mL, delivers 50 mg CBN (dosage level investigated in 2024 sleep literature).
• At 1.0 mL, delivers 25 mg CBN (above the 20 mg threshold associated with reduced sleep disturbance).
• Evidence context: CBN sleep [16][17], cannabis and sleep review literature.

Anxiety & Stress

• Daytime (functional relief): 0.3 mL raw sublingual (CBD + CBG for anxiety without impairment).
• Nighttime: 1.0 mL sublingual (full cannabinoid profile + CBN for sleep architecture).
• Evidence context: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage effect [20].

General Titration Principle

✅ Start low, go slow.
✅ Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing.
✅ Individual responses vary based on body weight, metabolism, tolerance, medications, and other factors.

OilWell RSO: Two Product Formats for Different Needs

1. RSO Sublingual Oil ($129.99)

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg/mL)
• Seven cannabinoids:
  • CBD: 4,500 mg
  • CBG: 3,000 mg
  • Delta-8 THC: 6,000 mg
  • THCa: 1,500 mg
  • Delta-9 THC: 90 mg
  • CBN: 750 mg
  • CBC: 750 mg
• Live terpenes at 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Organic MCT oil base (neutral taste, better absorption)
• Graduated dropper for precise dosing (0.1 mL increments)
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (sublingual route partially bypasses first-pass liver metabolism)
• ~40-60 doses per bottle (depending on serving size)

2. RSO Vape Cartridge ($49.99)

• 1-gram cartridge
• 900+ mg total cannabinoids
• Six cannabinoids (same ratio as sublingual, but no delta-9 THC listed separately—THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest cannabinoid delivery method)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable, dependent on inhalation technique)
• Automatic THCa decarboxylation at vaping temperature (400-450°F)

When to Use Each Format: A Quick Guide

Use Case	Recommended Format	Why?
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability & discretion	Vape	Compact, no measuring required
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive use	Sublingual (raw, no heat)	THCa stays inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC

How OilWell RSO Compares to Alternatives

OilWell RSO vs. Texas TCUP Dispensary RSO

Dimension	TCUP Dispensary RSO	OilWell RSO
Cannabinoid Profile	THC-only (~420 mg THC per 0.5 g syringe)	7 cannabinoids (CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC)
CBG Content	0 mg	3,000 mg
CBN Content	0 mg	750 mg
CBC Content	0 mg	750 mg
Patient-Controlled Potency	No—always fully psychoactive	Yes—THCa non-psychoactive until heated by customer
Access Requirements	TCUP medical card with qualifying condition	Age 21+ only, no medical card required
Delivery	Must travel to physical dispensary	Same-day delivery in Houston, nationwide/international shipping
Farm Bill Compliant	No—state medical cannabis program	Yes—<0.3% delta-9 THC

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

Dimension	Lazarus Naturals RSO (10 mL, 1,000 mg)	OilWell RSO (30 mL, 16,590 mg)
Total Cannabinoids	1,000 mg	16,590 mg
CBD Content	~950 mg	4,500 mg
CBG Content	15.5 mg	3,000 mg
CBN Content	0.7 mg	750 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible to delta-9 THC)	Minimal	1,500 mg (converts to ~1,315 mg delta-9 THC)
Psychoactive Option	No meaningful psychoactive effect	Yes—via THCa decarboxylation and delta-8 THC
Approximate Price	$40-$50	$129.99

Delivery & Accessibility for Bingham County, Idaho

OilWell operates the only same-day RSO delivery system in Houston, but we also ship nationwide and internationally—including to Bingham County, Idaho.

Houston Same-Day Delivery

Zone	Coverage	Delivery Fee	Typical Turnaround
Texas Medical Center	All 60+ TMC institutions (MD Anderson, Memorial Hermann, Methodist, Texas Children’s, St. Luke’s, etc.)	FREE	2-4 hours
Inner Loop (610)	Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks, Upper Kirby, Galleria	$5	2-4 hours
Within Beltway 8	Bellaire, Memorial, Spring Branch, South Houston, Pasadena (partial), Hobby Airport area	$10	3-5 hours
Greater Houston Suburbs	Katy, Sugar Land, Pearland, Clear Lake, The Woodlands, Cypress, Tomball, Humble, Kingwood	$15	4-6 hours
Extended Region (60 miles)	Galveston, Baytown, Rosenberg, Conroe, La Porte, Seabrook	$20-$25	Same-day if ordered before 2 PM

Free delivery to the Texas Medical Center (TMC)—the world’s largest medical complex with over 10 million patient visits annually—reflects OilWell’s commitment to accessibility for patients who need it most.

Nationwide Shipping (Including Idaho)

• All 50 states where Farm Bill-compliant products are legal.
• USPS Priority Mail (2-3 business days)
• FedEx & UPS Ground (3-5 business days)
• Discreet packaging (no cannabis branding visible)
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments
• Signature-required option available

International Shipping

OilWell ships internationally and has already delivered to multiple countries across multiple continents. The THCa legal framework makes this possible:

• The product contains <0.3% delta-9 THC at point of sale, meeting the definition of a hemp-derived product under the 2018 Farm Bill.
• Legal in jurisdictions where hemp-derived products are permitted.

International shipping details:

• All packages include full documentation, Certificates of Analysis (COAs), and receipts for customs.
• Minimum flat-fee shipping applies; excessive shipping costs are billed to the customer.
• Customer is responsible for verifying local legality and accepts all customs/legal risk.
• Contact: (832) 416-2816 or [email protected]

Why this matters for Bingham County, Idaho:

• No medical card required—just age 21+.
• No need to visit a dispensary—order online and have it shipped discreetly to your door.
• Full transparency—COAs, lab results, and open-source formulas available.

The Science Behind OilWell’s Formula: How It Connects to the Evidence

Every cannabinoid and terpene in OilWell’s RSO formula has its own evidence profile in the GENERAL KNOWLEDGE section of this document.

Cannabinoids in OilWell RSO

Cannabinoid	Amount in Sublingual Oil	Key Evidence Summary
CBD	4,500 mg	Strongest human evidence (epilepsy, anxiety, pain); FDA-approved for seizures [1]-[6].
CBG	3,000 mg	Emerging preclinical evidence (neuroprotection, IBD, antibacterial); human trials still limited [7][8].
Delta-8 THC	6,000 mg	Psychoactive, less potent than delta-9; limited human safety data [9]-[11].
THCa	1,500 mg	Non-psychoactive precursor to THC; potential anti-inflammatory/neuroprotective effects [12].
Delta-9 THC	90 mg	Strong human evidence (pain, nausea, appetite); psychoactive risks (anxiety, impairment) [1][13]-[15].
CBN	750 mg	Weak human evidence for sleep; marketing claims outpace science [16][17].
CBC	750 mg	Preclinical evidence (neurogenesis, antibacterial); not yet clinically validated [18][19].

Terpenes in OilWell RSO

Terpene	Potential Benefits	Evidence Level
Limonene	Mood enhancement, stress relief	Preclinical, review-level [20]-[22]
Myrcene	Relaxation, sedation	Preclinical, limited human [20][23]
β-Caryophyllene	Anti-inflammatory (CB2 agonist)	Preclinical, mechanistic [24]
Pinene	Alertness, memory support	Preclinical, review-level [20][25]
Linalool	Calming, anxiety relief	Preclinical, review-level [20][22][25][26]
Humulene	Anti-inflammatory, appetite suppressant	Preclinical, review-level [20][27]
Terpinolene	Antioxidant, uplifting	Preclinical, review-level [20][28]

The Entourage Effect: Does It Really Work?

The entourage effect is the theory that cannabinoids and terpenes work better together than in isolation. While this idea is plausible and widely discussed, the human clinical evidence remains limited [20][29].

What we know:
✅ Preclinical evidence (lab/animal studies) supports synergistic effects between cannabinoids and terpenes.
✅ Some human studies (e.g., terpenes + THC for anxiety) show potential benefits.
❌ No large-scale clinical trials have definitively proven the entourage effect in humans.

OilWell’s approach:
We include live terpenes at 5% because:

• The science is plausible.
• Terpenes enhance flavor and aroma (improving the user experience).
• They may contribute to therapeutic effects, even if the evidence is still developing.

Common Overstatements to Avoid (And What the Science Actually Says)

Overstatement	What the Science Actually Says
“CBN is a clinically proven sleep aid.”	The sleep evidence for CBN is weak and dated; no strong human trials support this [16][17].
“Myrcene is a proven sedative that causes couch-lock.”	Myrcene has preclinical bioactivity, but direct human proof for sedation is limited [20][23].
“Terpenes have proven entourage effects in patients.”	Entourage hypotheses are influential, but robust clinical proof remains limited [20][29].
“THCa is always non-psychoactive.”	THCa itself is not psychoactive, but heating or processing can convert it to THC [12].
“Delta-8 THC is safe because it’s hemp-derived.”	Delta-8 is psychoactive, pharmacologically similar to delta-9, and often entangled with manufacturing concerns [9]-[11].

Safety & Legal Considerations for Bingham County, Idaho

Age Requirement

• 21+ to purchase OilWell RSO products.

THC Content Compliance

• All OilWell products contain <0.3% delta-9 THC (Farm Bill compliant, hemp-derived).
• THCa is legal at point of sale (non-psychoactive until heated).

FDA Disclaimers

• These products have not been evaluated by the FDA.
• They are not intended to diagnose, treat, cure, or prevent any disease.
• Consult a healthcare provider before use, especially if pregnant, nursing, or taking medications.
• Individual results may vary.

Safety Warnings

• May cause drowsiness or impairment.
• Do not operate vehicles or machinery while under the influence.
• Consult a physician if pregnant or nursing.
• Keep out of reach of children.
• Start with low doses and titrate slowly.

Legal Responsibility

• Buyer is responsible for checking local laws.
• OilWell assumes no legal responsibility for customer’s use or decarboxylation decisions.
• Void where prohibited by law.

Idaho-Specific Considerations

Idaho has some of the strictest cannabis laws in the U.S.:

• Hemp-derived CBD with 0% THC is legal (but heavily restricted).
• Any amount of THC (including delta-8, delta-9, or THCa that converts to THC) is illegal under Idaho law.
• Possession of any THC product (including decarboxylated RSO) can result in felony charges.

OilWell’s Position:

• Our RSO sublingual oil contains <0.3% delta-9 THC at point of sale (legal under federal law).
• THCa is non-psychoactive until heated—but decarboxylation converts it to THC, which is illegal in Idaho.
• We do not recommend purchasing or using OilWell RSO in Idaho unless you are fully aware of and compliant with Idaho state laws.
• International customers must verify local legality before ordering.

Why Choose OilWell RSO? The Four Core Principles

1. Accessibility Over Gatekeeping

• No medical card required—just age 21+.
• Ships nationwide (where legal) and internationally.
• Same-day delivery in Houston for local patients.

2. Patient-Controlled Potency

• THCa allows non-psychoactive use (raw) or full psychoactive effects (decarbed).
• You decide—not the product, not the government.

3. Open-Source Formulas

• Complete formulas published publicly—if you can’t afford our product, you can make your own.
• Bentley’s CBD golden paste recipe (the formula that saved his life) is available for free on our website.

4. Evidence-Informed, Not Evidence-Overstating

• Every claim is backed by peer-reviewed research (see GENERAL KNOWLEDGE section).
• We don’t make unsupported promises—we provide honest education so you can decide for yourself.

Final Thoughts: RSO in Bingham County, Idaho—What’s Next?

Rick Simpson Oil (RSO) has a powerful legacy—it brought global attention to the therapeutic potential of cannabis and inspired countless patients to explore alternative treatments. However, traditional RSO had significant limitations:
❌ Unstandardized potency (batch-to-batch variability)
❌ No lab testing (contaminant risks)
❌ Extremely high THC exposure (psychoactive risks)
❌ No terpenes (missing potential entourage effects)
❌ No patient-controlled potency (always psychoactive)

OilWell RSO addresses these limitations with:
✅ Standardized, lab-tested cannabinoid profiles
✅ Solvent-free production (no toxic residues)
✅ Patient-controlled potency (raw or decarbed)
✅ Live terpenes at 5% (for potential entourage effects)
✅ Two delivery formats (sublingual + vape)

For Bingham County, Idaho residents:

• Idaho’s laws are strict—THC in any form is illegal, including decarboxylated RSO.
• If you’re exploring RSO for medical reasons, we strongly recommend consulting a healthcare provider and considering legal alternatives (e.g., CBD isolate, which is legal in Idaho).
• If you’re in a state where hemp-derived THCa is legal, OilWell RSO offers a modern, evidence-informed, patient-controlled alternative to traditional RSO.

The future of RSO is not about hype—it’s about honesty, science, and patient empowerment. At OilWell, we’re committed to providing the best possible version of the information so you can make informed decisions about whether RSO is right for you.

Have questions? We’re here to help.
📞 Phone: (832) 416-2816
📧 Email: [email protected]
🌐 Website: https://oilwellcbd.com/
📍 Location: 810 Richmond Ave, Houston, TX 77006 (Montrose neighborhood)

Stay informed. Stay empowered. Stay well. 🌿